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Abstract
Background: Depression is common among people with diabetes, negatively affecting quality of life,
treatment adherence and diabetes outcomes. In routine clinical care, diabetes patients have limited access
to mental health services and depression therefore often remains untreated. Web-based therapy could
potentially be an effective way to improve the reach of psychological care for diabetes patients, at relatively
low costs. This study seeks to test the effectiveness of a web-based self-help depression programme for
people with diabetes and co-morbid depression.
Methods/Design: The effectiveness of a web-based self-help course for adults with diabetes with co-
morbid depression will be tested in a randomised trial, using a wait-list controlled design. The intervention
consists of an 8-week, moderated self-help course that is tailored to the needs of persons living with
diabetes and is offered on an individual basis. Participants receive feedback on their homework assignments
by e-mail from their coach. We aim to include 286 patients (143/143), as power analyses showed that this
number is needed to detect an effect size of 0.35, with measurements at baseline, directly after completing
the web-based intervention and at 1, 3, 4 and 6 months follow-up. Patients in the control condition are
placed on a waiting list, and follow the course 12 weeks after randomisation.
Primary outcomes are depressive symptoms and diabetes-specific emotional distress. Secondary
outcomes are satisfaction with the course, perceived health status, self-care behaviours, glycaemic control,
and days in bed/absence from work. Questionnaires are administered via the Internet.
Discussion: The intervention being trialled is expected to help improve mood and reduce diabetes-
specific emotional distress in diabetes patients with depression, with subsequent beneficial effects on
diabetes self-care and glycaemic outcomes. When proven efficacious, the intervention could be
disseminated to reach large groups of patients with diabetes and concurrent depressive symptoms.
Trial registration: Current Controlled Trials ISRCTN24874457
Published: 19 February 2008
BMC Psychiatry 2008, 8:9 doi:10.1186/1471-244X-8-9
Received: 17 January 2008
Accepted: 19 February 2008
This article is available from: http://www.biomedcentral.com/1471-244X/8/9
© 2008 van Bastelaar et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 7
(page number not for citation purposes)
BMC Psychiatry 2008, 8:9 http://www.biomedcentral.com/1471-244X/8/9Background
Depression has been shown two times more prevalent
among persons with type 1 or type 2 diabetes, compared
to the general population [1]. Approximately 10% of the
adult diabetes patient population suffers from major
depressive disorder and another 10% from minor depres-
sion [1]. Data also suggest depression to be more persist-
ent and recurrent in people with diabetes [2]. The costs of
depression in diabetes are known to be high, not only in
terms of suffering and reduced quality of life, but also in
view of adverse medical outcomes (e.g. hyperglycaemia,
diabetes complications), and societal and economic costs
[3,4].
Based on evidence to date, psychological therapy (partic-
ularly cognitive behaviour therapy, CBT) is the treatment
of choice for depression [5]. Only a few randomised con-
trolled studies have been conducted to test the efficacy of
anti-depressant therapies in persons with diabetes and co
morbid depression [6-8].
Not surprisingly, depressive symptoms are likely to co-
occur with high levels of diabetes-related emotional dis-
tress, as was confirmed in a recent international study [9].
While the optimal treatment for depression in diabetes is
still being sought [10], there is good reason to assume that
the efficacy of anti-depressant psychotherapy in diabetes
can be enhanced when specific issues associated with the
burden of living with this chronic disease are adequately
addressed [11].
We recently conducted a study to test the effectiveness of
a group Cognitive Behaviour Therapy (CBT) developed
for patients in prolonged poor glycaemic control in a RCT,
and found CBT to be most effective in patients who
entered the study with elevated depression scores [12,13].
Offering diabetes-specific CBT to diabetes patients with
depression should thus be able to improve psychological
health, self-management behaviours and subsequent
medical outcomes. However, access to psychological serv-
ices is limited, both in primary and secondary routine dia-
betes care [10]. As pointed out by Glasgow et al [14], we
need to consider ways to enhance dissemination of effec-
tive psychological interventions to persons with diabetes.
In this context, we believe use of modern interactive tech-
nology, such as internet-based therapy should be consid-
ered. More so, since web-based psychological
interventions have shown their utility across a range of
problem areas and are likely to be cost-effective [15,16].
Web-based cognitive behaviour therapy (W-CBT) is recog-
nized as an effective treatment option for depression and
appeared to be well appreciated by patients [15,17-20]. In
The Netherlands, we have seen an increase of internet-use
in the past years, with about 83% of the households cur-
rently being "online" [21]. Internet-based therapy there-
fore has great potential to reach large groups of diabetes
patients with co-morbid depression. To our knowledge,
we would be the first to test the effectiveness of diabetes-
specific on-line CBT for depression in persons with diabe-
tes.
Aims of the Trial
This study aims to test the effectiveness and appreciation
of web-based cognitive behavioural therapy (W-CBT) for
adult diabetes patients with depression in a randomized
controlled trial. The experimental condition will be com-
pared with a waiting-list control group. It is hypothesized,
that W-CBT will be well-received by the participants and
will appear to be significantly more effective than the con-
trol condition in reducing levels of depressed mood and
diabetes-specific emotional distress, with subsequent pos-
itive effects on self-management behaviours and glycae-
mic control on the longer term.
Methods/Design
Study Design
We chose a two-arm randomised controlled trial (RCT)
design; including 286 patients (143/143) (see power cal-
culation). Measurements are scheduled at six points in
time in the intervention group: at baseline, directly after
completing the web-based intervention, and at 1, 3, 4 and
6 months follow-up. In the control group the same six
measurements are scheduled with two additional meas-
urements at 8 and 12 weeks after randomization (see flow
chart, Figure 1).
Study procedures
The recruitment and screening procedure has been devel-
oped, so that patients interested in joining the study can
visit the research website. There, the patient will be invited
to read the study information and provide written
informed consent. After receipt of the consent form, the
patient will receive a password per e-mail allowing him/
her to log in and complete the online screening questions.
For the baseline measurement, patients are invited to fill
out a booklet of questionnaires on the Internet, -which
will take approximately 30 minutes-containing demo-
graphic data, in – and exclusion criteria, and depressive
symptoms (Center for Epidemiological Studies Depres-
sion scale (CES-D) >16) [22]. If a patient does not qualify,
this is explained and the patient is advised to contact his/
her GP for further advice. If eligible, the patient will be
interviewed by telephone using the Composite Interna-
tional Diagnostic Interview (CIDI). Data from this CIDI
interview will be used to specify type of mood disorder
(DSM-IV). Those with bipolar disorder, depression with
psychotic features and patients who suffer from currentPage 2 of 7
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Flow chart of participantsigure 1
Flow chart of participants. AD: anti-depressives; CES-D: Center for Epidemiologic Studies Depression scale; PAID: Prob-
lem Areas In Diabetes scale; ADSCI: Diabetes Self-care Inventory; SF-12: Short-Form-12; EQ-5D: Euroqol 5D; CBT: Cognitive 
behavioural therapy.
Recruitment of patients via 
advertisement in 
(outpatient) clinics, patient 
journals and websites 
Not included:  
No computer, no (easy) 
access to the internet, no 
e-mail address, 
insufficient Dutch 
language skills, visually 
too impaired to read, 
insufficient computer 
skills
Excluded:  
Not motivated; < 18 
years of age; not 
diagnosed with diabetes 
by a physician; pregnant; 
currently taking AD 
medication; co-morbid 
organic psychiatric 
disorder, loss of 
significant other > 6 
moths ago; history of 
suicide attempts; current 
suicidal ideation 
Self-assessment of 
eligibility, based on 
exclusion criteria mentioned 
on the study website 
Randomisation
Telephone administered 
CIDI interview –sections 
depression and anxiety 
Baseline measurement 
(PAID, ADSCI, SF-12, EQ-
5D, HbA1c)
Excluded:  
No elevated depressive 
symptoms, bipolar 
disorder, depression with 
psychotic features and 
patients who suffer from 
current suicidal ideation  
Excluded:  
Exclusion criteria; CES-D 
no depression (<16) 
Excluded: No informed 
consent
Informed consent
Assessment of eligibility 
based on online 
administered demographic 
questions, in- and exclusion 
questions, CES-D 
Intervention condition: 
Web-based CBT 
8 weeks 
Control condition:  
Waiting list 
Follow-up
1 and 6 months after 
completion of the course 
Completion of the course. 
Post measurement 
Follow-up
12 weeks after 
randomisation;
Web-based CBT 
Post measurement 
8 weeks after 
randomisation
Loss to follow-up 
Loss to follow-up 
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firmed the patient is enrolled in the study.
Treatment allocation
Randomisation by computer will assign individual
patients to either the experimental or control condition.
Recruitment
The on-line depression course will be delivered through a
website. The study will be advertised in the Netherlands
and Flanders (Dutch speaking part of Belgium) in clinics
(e.g. hospitals, GP's, pharmacy's, rehabilitation centres)
and through various media (e.g. patient journals, special-
ist journals, websites, e-mails, flyers, newspapers etc.). It
will be advertised as a web-based course for persons with
diabetes (type 1 or type 2) to help improve a depressed
mood. Patient information on the study will be available
on the research website. Inclusion and exclusion criteria
will be stated clearly on this website.
Study population
The source population consists of adult diabetes patients
with co-morbid depression. Blinding of subjects will -due
to ethical reasons- not be carried out.
Inclusion criteria are: ≥18 years of age; having type 1 or
type 2 diabetes (diagnosed > 3 months prior to study by a
physician); having a depressed mood, as indicated by a
score of 16 or higher on the Center for Epidemiological
Studies Depression scale (CES-D); depression diagnosed
by the CIDI-interview; having access to the Internet at
home and having an e-mail address.
Exclusion criteria are: not having easy access to the Inter-
net, reading problems (e.g. due to insufficient Dutch lan-
guage skills, visual impairments or illiteracy); currently
taking anti-depressant medication; a history of suicide
attempt(s); current suicidal ideation (measured with the
CIDI); bipolar disorder (CIDI); co-morbid organic psychi-
atric disorder (CIDI); loss of significant other < previous 6
months; or pregnancy.
Description of interventions
Intervention group
Patient enrolment will occur individually on a continuous
basis, i.e. at any point in time during the study period. The
number of included participants is not limited by physical
capacity other than the number of coaches available. After
inclusion criteria are met and the patient has returned the
informed consent s/he will be randomly assigned to the
intervention or the control group.
Patients assigned to the intervention group will receive a
password per e-mail with which they can log in to the
course. They will be instructed (and reminded per e-mail)
to complete one session per week, during 8 consecutive
weeks.
Coaches will send e-mails to participants as a way to
encourage them to continue their efforts. Such reinforce-
ment should help to keep patients on track with the
course and lower the risk of drop-out. They also provide
the participants with feedback on their homework assign-
ments. It is clearly stated that coaches will not give advice
on personal issues.
Control group
Control group patients will receive an e-mail in which
they are informed of the randomisation result, which
means they will start the course after 12 weeks. To reduce
the risk of loss of interest; participants placed on the wait-
ing-list will automatically receive weekly protocollised e-
mails with motivating, positive feedback to enforce them
to remain involved in the study.
After eight weeks they are invited per e-mail to fill in the
questionnaires again. Twelve weeks after randomization
patients will undergo a second screening (using the CES-
D-score ≥ 16 as a first screener for depression and addi-
tionally the CIDI interview) to confirm depression. If still
eligible, the patient is invited to follow the course.
Patients, who do not qualify, i.e. show (spontaneous)
remission, are excluded at this point. Patients who devel-
oped suicidal ideation during the 12 weeks waiting
period, are offered the opportunity to have an appoint-
ment with a diabetes psychologist of the VU University
Medical Centre or a colleague nearby in case the distance
from the participant's home to the VUMC should be prob-
lematic.
The effectiveness of the intervention is determined
directly after completing the web-based intervention up
till 6 months follow-up (see Consort flow chart in Figure
1).
If the depression has deteriorated at the end of the course,
as indicated by the scores of the CES-D, a consultation
with a diabetes psychologist at the VU Medical Centre is
offered to the patient. In agreement with their General
Practitioner a decision will be made about further treat-
ment or hospitalization.
Intervention development and trial design
The Dutch version of the manual-based self-help course
named 'Coping with Depression' ('In de put, uit de put')
has been adapted as web-based intervention ('Kleur je
Leven') [23,24]. This intervention has been adjusted fur-
ther by our team to fit the needs of patients with diabetes
('Diabetergestemd'). Based on our research, clinical expe-
rience and input from an expert panel of diabetes patients,Page 4 of 7
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test results, uncertainty about blood glucose fluctuations
and negative emotions, communication with health care
professionals, talking about diabetes with others, the bur-
den of daily self-management, and coping with diabetes-
related worries (e.g. about hypoglycaemia and late com-
plications). The course consists of 8 consecutive weekly
lessons. The course will provide information, practice
examples, exercises/self-tests and homework assignments.
The web-based course is delivered on an individual basis.
Patients weekly receive (protocollized) feedback on their
homework assignments from their coaches by e-mail. The
coaches are psychologists and residents in clinical psy-
chology from the department of Medical Psychology of
the VU medical centre, supervised by the research team.
An internet-based group forum, which will be moderated
by our team, is offered to participants to give them the
opportunity to share experiences, provide support and
discuss issues related to depression and diabetes [25]. In
the forum, specific treatment issues (e.g. related to oral
medication or insulin) may not apply to all participants,
but this should not be problematic. Rather, the mix of dis-
ease types and experiences can serve to illustrate the com-
mon features of diabetes and depression (thoughts,
emotions and behaviors), while respecting individual dif-
ferences.
It will be clearly stated that during the course of the study,
all participants are allowed to make use of additional
mental health care services if they feel a need to do so.
Outcome Assessment
Primary outcome measures
Primary outcome measure is the level of depression,
measured by the online administered self-reported
depression questionnaire Center for Epidemiological
Studies Depression scale (CES-D) [26] at baseline, directly
after completion of the course and at one and six months
follow-up.
Secondary outcome measures
Secondary outcome measures are: diabetes-specific emo-
tional distress (PAID) [27], satisfaction with the course
(self-developed questions), perceived health status
(EQ5D and SF-12) [28], diabetes self-care behaviours
(Amsterdam Diabetes Self Care Inventory), self-reported
episodes of hypoglycaemia and glycaemic control
(HbA1c) retrieved from the patients' medical charts via
their physician.
Covariates
Additionally, information on potentially confounding
factors and effect modifiers will be collected by means of
self-report: socio-demographic data (age, gender, marital
status, highest level of completed education, and current
occupation), lifestyle issues (smoking, body mass index
(BMI), substance/alcohol abuse), data on diabetes (type
of diabetes, duration, treatment regimen, co-morbidity)
and additional mental health care consumption.
Statistical Analyses
Analyses will be conducted according to the intention to
treat principle. The data will be presented as categorical
and continuous variables. Baseline characteristics will be
compared for the intervention and waiting-list group
using Student t-tests and χ2-tests. Analysis of variance
(ANOVA) will be conducted with the CES-D (depression)
as dependent variable, with two independent variables:
time (within-subject) and group (between-subject). The
same analysis will be performed with the PAID score (dia-
betes-related emotional distress) as dependent variable.
Two analyses will be conducted. Firstly, the direct effect of
the intervention will be determined. ANCOVA's will be
performed in order to test whether both groups have dif-
ferent scores on the CES-D, at different points in time,
with correction for potential confounders at baseline. Sec-
ondly, pre-post measurements will be conducted of all
participants who have received the intervention. This will
be analysed by means of a longitudinal regression analy-
sis, which will be performed using Generalized Estimating
Equations (GEE) [29], taking into account the correla-
tional nature of repeated measures data within subjects,
and securing minimal loss of patients due to incomplete
data. Clinical effectiveness will be calculated by the
amount of people who after completion of the course
have a score on the CES-D of <16. The effect size will be
calculated using Cohen's d [30].
Power calculation
The sample size was calculated using STATA, based on
clinically relevant differences. Effect Sizes (ES) are calcu-
lated as the difference between the control group and the
intervention group after the intervention, divided by the
pooled standard deviation [30]. With 100/100 patients
the study is powered to detect an ES of 0.35 (one-sided),
with a power of 80% (α = 0.05). Based on a meta-analysis
[23], we may expect an ES of 0.5 to 0.6 [18]. We anticipate
30% non-completion/exclusion, which will be compen-
sated by over sampling (n = 286; 143 in each group).
Discussion
Strengths and Limitations
To the best of our knowledge, this randomised controlled
trial will be the first to test the effects of a web-based CBT
self-help course for people with diabetes and co-morbid
depression. The intervention builds on an existing course
that has shown to be feasible and effective to help
improve mood in the general population [31]. Our trial is
sufficiently powered to allow for conclusions as to its
short-term effectiveness (6 months). In view of the "leni-Page 5 of 7
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study is expected to have high external validity.
An obvious limitation of this trial is the fact that only peo-
ple with access to the Internet and sufficient computer
skills can be included. Overall, an estimated 82% of the
Dutch households are online in 2007, but access to Inter-
net among the elderly is much lower [21] and as a conse-
quence this group may therefore be under represented in
our study.
Inclusion and exclusion criteria are clearly stated on the
website. This has the potential disadvantage that people
can pretend to have certain characteristics in order to qual-
ify or they can deny having "exclusion criteria". However,
this response tendency may be diminished by the fact that
patients are being made aware that we inform their GP's
of their participation in the study and that we will be in
contact with their treating physician concerning their
HbA1c results.
As the post-treatment assessment will be done directly
after treatment and up till 6 months follow-up, no conclu-
sions can be drawn about the long-term effects of the
intervention. Therefore, after 6 months, patients will be
asked to give permission for supplemental follow-up
measurements at one and two years after completion of
the course. These results will be analysed at a later stage
and are not part of this project.
Although web-based administration of questionnaires is
widely used, we should remind ourselves that the psycho-
metric properties of internet-administered questionnaires
may not be equal to those of paper-and-pencil versions
[32]. On the other hand, in an earlier study we have found
that the paper-and-pencil and the computerised versions
of a short psychological well-being questionnaire
appeared to be equivalent [33]. The major difference
appears to be that respondents are more honest and
revealing when filling out via the Internet, resulting in a
relatively higher reported level of symptomatology. We
have therefore chosen to confirm or decline the diagnosis
of depression by a telephone administered diagnostic
interview (CIDI). Our study will show if such diagnostic
procedure is required in future projects applying W-CBT
in order to reduce the risk of 'false positives'.
Also the psychometric properties of the following on-line
questionnaires will be examined and compared to the
paper-and-pencil versions: the PAID, SF-12 and the
ADSCI.
We hypothesise that improved mood will be associated
with improved diabetes self-management and we will test
whether W-CBT has favourable effects on self-reported
diabetes self-care behaviours, using the Amsterdam Dia-
betes Self-care Inventory (ADSCI) that was developed by
our team and used in previous trials [12,13,34]. The psy-
chometric properties of the Amsterdam Diabetes Self Care
Inventory (ADSCI) have not yet been published, but a
report on the validity and reliability of the scale is planned
based on data on file.
Ethical and practical considerations have led us to decide
that all participants are allowed to use additional mental
health care (MHC) services during the trial. Usage of addi-
tional services therefore is a potential confounder that will
be measured and taken into account in the statistical anal-
yses.
Drop-out is often a problem in web-based therapy trials.
In adapting the generic coping with depression course to
the needs of people with diabetes, we expect to reduce
drop-out. In an attempt to further reduce the attrition rate,
support e-mails will be send out to participants by their
coach, to encourage them to stay involved in the course.
Likewise, those in the waiting list condition will receive e-
mails aimed to maintain contact and encourage them to
participate.
The study protocol was approved by the VU University
Medical Centre ethics committee, which is certified by the
Central Committee on Research involving Human Sub-
jects in the Netherlands.
Future implementation
If this intervention proves to be effective in reducing
depression and shows to be well appreciated by diabetes
patients, further dissemination of the intervention is
anticipated. An implementation and dissemination plan
is under development.
This intervention could also be adapted to suit the needs
of people who suffer from chronic diseases other than dia-
betes.
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